LipoScience seeks FDA clearance for cardiovascular testing device

02/1/2010 | American City Business Journals

LipoScience has filed an application with the FDA seeking clearance for Vantera, a device that would enable research laboratories to conduct on-site testing of blood samples for risks of heart diseases. CEO Rick Brajer said he is hopeful the company can secure FDA clearance later this year.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA